Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction

Clinical and Experimental Immunology - Tập 129 Số 3 - Trang 464-470 - 2002
Mayumi Ueta1,2, M-N Kweon1, Y Sano2, Chie Sotozono2, Jun Yamada2, Noriko Koizumi2, Hiroshi Kiyono1, Shigeru Kinoshita2
1Department of Mucosal Immunology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan
2Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto

Tóm tắt

SUMMARYThe combination of allograft limbal transplantation (ALT) and amniotic membrane transplantation (AMT) has been applied in the treatment of severe ocular surface diseases. The beneficial effect of this combination has been thought to result from possible immunosuppressive ability of amniotic membrane (AM). However, the mechanisms of any such ability remain unknown. In this study, we investigated whether human AM has the ability to suppress allo-reactive T cell responses in vitro. For mixed lymphocyte reaction (MLR), lymphocytes isolated from lymph nodes of C57BL/6 mice (Mls1b, Vβ6+) were cultured with irradiated splenocytes from DBA/2 mice (Mls1a, Vβ6−) with or without human AM. For carboxyfluorescein diacetate succinimidyl ester (CFSE) experiments, responder lymph node cells were labelled with a stable intracellular fluorescent dye and cultured with irradiated stimulator cells. The ratio of responder Vβ6+ T cells was then determined by FACS analysis, and the division profiles of responder Vβ6+ T cells were analysed by CFSE content. Furthermore, Th1 and Th2 cytokine synthesis by allo-reactive T cells in MLR culture supernatants was determined by enzyme-linked immunosorbent assay (ELISA). Addition of AM to the MLR culture resulted in the significant inhibition of thymidine incorporation compared with control culture lacking AM. The population of responder CD4+Vβ6+ T cells was significantly reduced in the AM-treated culture in comparison to control. CFSE analysis revealed less division and lower proliferation of responder CD4+Vβ6+ T cells in cultures with AM than without. In addition, allo-rective T cell synthesis of both Th1 (IL-2 and IFNγ) and Th2 (IL-6 and IL-10) type cytokine was significantly decreased in the presence of AM. These results indicate that human AM has the ability to suppress allo-reactive T cells in vitro. This inhibitory effect likely contributes to the success of the ALT-AMT combination.

Từ khóa


Tài liệu tham khảo

Kinoshita, 1982, Limbal epithelium in ocular surface wound healing, Invest Ophthalmol Vis Sci, 23, 73

Shapiro, 1981, Corneal re-epithelialization from the conjunctiva, Invest Ophthalmol Vis Sci, 21, 135

Schermer, 1986, Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells, J Cell Biol, 103, 49, 10.1083/jcb.103.1.49

Cotsarelis, 1989, Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells, Cell, 57, 201, 10.1016/0092-8674(89)90958-6

Huang, 1991, Corneal epithelial wound healing in the absence of limbal epithelium, Invest Ophthalmol Vis Sci, 32, 96

Tseng, 1989, Concept and application of limbal stem cells, Eye, 3, 141, 10.1038/eye.1989.22

Kinoshita, 1986, Corneal Surgery, 309

Kenyon, 1989, Limbal autograft transplantation for ocular surface disorders, Ophthalmology, 96, 709, 10.1016/S0161-6420(89)32833-8

Tsai, 1994, Human allograft limbal transplantation for corneal surface reconstruction, Cornea, 13, 389, 10.1097/00003226-199409000-00003

Tsubota, 1995, Reconstruction of the corneal epi-thelium by limbal allograft transplantation for severe ocular surface disorders, Ophthalmology, 102, 1486, 10.1016/S0161-6420(95)30841-X

Holland, 1996, The evolution of epithelial transplantation for severe ocular surface disease and a proposed classification system, Cornea, 15, 549, 10.1097/00003226-199611000-00003

Kim, 1995, Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas, Cornea, 14, 473, 10.1097/00003226-199509000-00006

Van Herendael, 1978, Microanatomy of the human amniotic membranes. A light microscopic, transmission, and scanning electron microscopic study, Am J Obstet Gynecol, 131, 872, 10.1016/S0002-9378(16)33135-0

Modesti, 1989, Localization of type IV and V collagens in the stroma of human amnion, Prog Clin Biol Res, 296, 459

Trelford, 1979, The amnion in surgery, past and present, Am J Obstet Gynecol, 134, 833, 10.1016/0002-9378(79)90957-8

Prasad, 1986, Use of amnion for the treatment of Stevens–Johnson syndrome, J Trauma, 26, 945, 10.1097/00005373-198610000-00016

Subrahmanyam, 1995, Amniotic membrane as a cover for microskin grafts, Br J Plast Surg, 48, 477, 10.1016/0007-1226(95)90123-X

Lwebuga-Mukasa, 1984, An acellular human amnionic membrane model for in vitro culture of type II pneumocytes: the role of the basement membrane in cell morphology and function, J Cell Physiol, 121, 215, 10.1002/jcp.1041210127

Van Der Linden, 1996, Endometrial cell adhesion in an in vitro model using intact amniotic membranes, Fertil Steril, 65, 76, 10.1016/S0015-0282(16)58030-3

Tsubota, 1996, Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens–Johnson syndrome, Am J Ophthalmol, 122, 38, 10.1016/S0002-9394(14)71962-2

Shimazaki, 1997, Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns, Ophthalmology, 104, 2068, 10.1016/S0161-6420(97)30057-8

Tseng, 1998, Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency, Arch Ophthalmol, 116, 431, 10.1001/archopht.116.4.431

Sionov, 1993, Trophoblasts protect the inner cell mass from macrophage destruction, Biol Reprod, 49, 588, 10.1095/biolreprod49.3.588

Beer, 1982, Placenta as an immunological barrier, Biol Reprod, 26, 15, 10.1095/biolreprod26.1.15

Koizumi, 2000, Cultivation of corneal epithelial cells on intact and denuded human amniotic membrane, Invest Ophthalmol Vis Sci, 41, 2506

Koizumi, 2000, Growth factor mRNA and protein in preserved human amniotic membrane, Curr Eye Res, 20, 173, 10.1076/0271-3683(200003)2031-9FT173

Koizumi, 2000, Amniotic membrane as a substrate for cultivating limbal corneal epithelial cells for autologous transplantation in rabbits, Cornea, 19, 65, 10.1097/00003226-200001000-00013

Williamson, 1989, Immunoregulatory properties of bone marrow-derived cells in the iris and ciliary body, Immunology, 67, 96

Fulcher, 1999, Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory, Immunol Cell Biol, 77, 559, 10.1046/j.1440-1711.1999.00870.x

Groth, 1999, Carboxyfluorescein diacetate succinimidyl ester and the virgin lymphocyte: a marriage made in heaven, Immunol Cell Biol, 77, 530, 10.1046/j.1440-1711.1999.00871.x

Okahashi, 1996, Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses, Infect Immun, 64, 1516, 10.1128/iai.64.5.1516-1525.1996

VanCott, 1996, Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella, J Immunol, 156, 1504, 10.4049/jimmunol.156.4.1504

Sutmuller, 1998, T-cell receptor Vbeta gene expression in experimental lupus nephritis, Immunology, 95, 18, 10.1046/j.1365-2567.1998.00565.x

Wells, 1997, Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response, J Clin Invest, 100, 3173, 10.1172/JCI119873

Streilein, 1996, Immunosuppressive properties of tissues obtained from eyes with experimentally manipulated corneas, Invest Ophthalmol Vis Sci, 37, 413

Helbig, 1990, Dual effect of ciliary body cells on T lymphocyte proliferation, Eur J Immunol, 20, 2457, 10.1002/eji.1830201115

Hori, 2000, Immune privilege and immunogenicity reside among different layers of the mouse cornea, Invest Ophthalmol Vis Sci, 41, 3032

Hori, 2000, Epithelium-deficient corneal allografts display immune privilege beneath the kidney capsule, Invest Ophthalmol Vis Sci, 41, 443

Zierhut, 1998, Mucosal immunology and the eye, Immunol Today, 19, 148, 10.1016/S0167-5699(97)01229-2

Cousins, 1991, Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor, Invest Ophthalmol Vis Sci, 32, 2201

Knisely, 1991, Production of latent trans-forming growth factor-beta and other inhibitory factors by cultured murine iris and ciliary body cells, Curr Eye Res, 10, 761, 10.3109/02713689109013870

Wilbanks, 1992, Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta, Eur J Immunol, 22, 1031, 10.1002/eji.1830220423

Granstein, 1990, Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation, J Immunol, 144, 3021, 10.4049/jimmunol.144.8.3021

Roth, 1996, Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10, J Exp Med, 184, 539, 10.1084/jem.184.2.539

Jones, 1995, Interleukin 4 production by human amnion epithelial cells and regulation of its activity by glycosaminoglycan binding, Biol Reprod, 52, 839, 10.1095/biolreprod52.4.839

Felli, 1996, Prostaglandin E2 inhibits the interleukin-2 promoter activity through down-regulation of the Oct – dependent transcription of the octamer motif, Cell Immunol, 172, 229, 10.1006/cimm.1996.0237

Choudhry, 1999, Prostaglandin E2 down- regulation of T cell IL-2 production is independent of IL-10 during gram-negative sepsis, Immunol Lett, 67, 125, 10.1016/S0165-2478(99)00003-6

Gurlo, 1998, PGE2 inhibits IL-2 and IL-4-dependent proliferation of CTLL-2 and HT2 cells, Cytokine, 10, 265, 10.1006/cyto.1997.0288

Riteau, 1999, HLA-G inhibits the allogeneic proliferative response, J Reprod Immunol, 43, 203, 10.1016/S0165-0378(99)00034-0

Rebmann, 1999, Detection of soluble HLA-G molecules in plasma and amniotic fluid, Tissue Antigens, 53, 14, 10.1034/j.1399-0039.1999.530102.x

Hammer, 1999, Fas and Fas-ligand are expressed in the uteroplacental unit of first-trimester pregnancy, Am J Reprod Immunol, 41, 41, 10.1111/j.1600-0897.1999.tb00074.x

Hammer, 2000, Expression of Fas-ligand in first trimester and term human placental villi, J Reprod Immunol, 46, 83, 10.1016/S0165-0378(99)00059-5

Runic, 1996, Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival, J Clin Endocrinol Metab, 81, 3119

Runic, 1998, Apoptosis and Fas expression in human fetal membranes, J Clin Endocrinol Metab, 83, 660

Thông tin
Thông tin xuất bản

Clinical and Experimental Immunology

Tập 129 Số 3

464-470

Thông tin tác giả